Analyst ratings and price target adjustments are significant indicators of a stock's future performance. UBS's downgrade from Buy to Sell, coupled with a drastic reduction in the price target for Rivian, suggests a bearish outlook on the company's financial health and market performance. This is likely to influence investor sentiment negatively, leading to a decrease in stock price in the short term.